Inventor
Frank Zenke
Inventor
Darmstadt, DE
Overview
Patents· 33 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes23%
C12NMicroorganisms or enzymes3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
C12YEnzymes2%
Y02ATechnologies for adaptation to climate change2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
PatentTitleYear
10,093,623Cyclic amides as MetAP-2 inhibitors201810,005,756Pyrrolidinone derivatives as MetAP-2 inhibitors20189,598,408'Imidazo[4,5-C]quinolines as DNA-PK inhibitors'20179,382,244'7-azaindole-2,7-naphthyridine derivative for the treatment of tumours'20169,151,743'Use of EEF1A as biomarker and a method of screening MetAP2 inhibitors'20159,126,952'Morpholinylquinazolines'20159,051,307'Bipyridyl derivatives'20159,051,318'Pyrido [2, 3-B] pyrazine compounds and their therapeutical uses such as for inhibiting ATP consuming proteins and treating diseases associated therewith'20159,000,153'Imidazo[4,5-c]quinolines as DNA-PK inhibitors'20158,987,301'Heteroarylaminoquinolines as TGF-beta receptor kinase inhibitors'20158,912,216'Hetaryl-[1,8]naphthyridine derivatives'20148,895,535'Pyrrolidinones as MetAP-2 inhibitors'20148,846,694'Pyrrolidone derivatives for use as MetAP-2 inhibitors'20148,846,931'Bipyridyl derivatives'20148,815,893'Hetarylaminonaphthyridines'20148,802,712'Pyrazoloquinolines'20148,791,113'2,4-diaryl-substituted [1,8] naphthyridines as kinase inhibitors for use against cancer'20148,614,226'Hetaryl-[1,8]naphthyridine derivatives'20138,546,406'Heterocyclic compounds as metap-2 inhibitors'20138,524,732'Substituted tetrahydroquinolines'20138,410,143'Methylene urea derivatives'20138,207,345'Tetrahydroquinolines for use as modulators of the mitotic motor protein Eg5'20128,110,583'Tetrahydroquinoline derivatives'20127,915,416'Tetrahydroquinolines'20117,893,082'Substituted tetrahydroquinolines'20117,875,614'Phthalazinones'20117,868,172'2-(hetero)-aryl substituted tetrahydroquinoline derivatives'20117,781,475'Oxindoles as kinase inhibitors'20107,691,886'Benzimidazole derivatives as raf kinase inhibitors'20107,691,870'Benzimidazole carboxamides as raf kinase inhibitors'20107,598,274'Pyrrole derivatives'20097,589,112'Methylene urea derivatives'20097,476,683'Glycinamide derivatives as raf-kinase inhibitors'2009Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2009–2018Patents assigned to MERCK PATENT GMBH (32)· patent assignee history
2009–2018Based in Darmstadt, DE· patent location history
2012–2015Patents assigned to ZENKE FRANK (17)· patent assignee history
2012–2015Patents assigned to AMENDT CHRISTIANE (10)· patent assignee history
2013–2015Patents assigned to JONCZYK ALFRED (7)· patent assignee history
2013–2015Patents assigned to DORSCH DIETER (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK PATENT GMBH | 32 | 2009–2018 |
| ZENKE FRANKself | 17 | 2012–2015 |
| AMENDT CHRISTIANE | 10 | 2012–2015 |
| JONCZYK ALFRED | 7 | 2013–2015 |
| DORSCH DIETER | 5 | 2013–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Darmstadt, DE | 33 | 2009–2018 |